HealthDataConsortium.org Editorial Team | April 27, 2026 | Informational only — not legal or medical advice. Laws subject to change; consult a licensed attorney for guidance specific to your situation.
Medical marijuana is now Schedule III. That is real, it is historic, and it matters. It is also not legalization. Six specific things didn't change on April 23, 2026, and each one affects a different group of people. Here is a precise account of what the rescheduling did not fix, why each gap exists, and what would actually be required to close it.
1. Recreational Marijuana Possession Is Still a Federal Crime
The April 23 order moved only FDA-approved marijuana products and state-licensed medical marijuana to Schedule III. Recreational cannabis — including products sold at adult-use dispensaries in California, Colorado, New York, and the other 21 recreational states — remains Schedule I under federal law. The DOJ order is explicit: “any form of marijuana other than in an FDA-approved drug product or marijuana subject to a state medical marijuana license remains a schedule I controlled substance,” and those who handle it “remain subject to the regulatory controls, and administrative, civil, and criminal sanctions” of Schedule I. Federal criminal penalties for unauthorized possession, distribution, and manufacturing still apply in full. State-law permission protects within state borders only.
Is recreational marijuana still federally illegal after the 2026 rescheduling?
Yes. Recreational marijuana remains Schedule I under federal law after the April 23, 2026 DOJ order. The order moved only FDA-approved marijuana products and state-licensed medical marijuana to Schedule III. Recreational marijuana — including products sold at adult-use dispensaries in any state — is not covered and remains a Schedule I controlled substance with full federal criminal penalties. The June 29, 2026 DEA hearing will determine whether recreational cannabis follows medical into Schedule III, but that outcome is not predetermined and a final rule is likely months away at minimum.
2. Synthetic THC Remains Schedule I
Synthetically derived THC is explicitly excluded from the April 23 rescheduling order. The order covers naturally derived delta-9-THC from the cannabis plant, but only when part of an FDA-approved product or covered by a state medical marijuana license. Synthetically derived cannabinoids — including delta-10-THC — remain Schedule I. Previously scheduled synthetic products like Marinol and Syndros are also unaffected. This is a nuance most consumer-facing coverage has missed entirely: “cannabis rescheduling” is accurate for natural medical products, but it is not a blanket reclassification of all THC-containing substances.
Is synthetic THC still illegal after the April 2026 cannabis rescheduling?
Yes. Synthetically derived THC remains Schedule I under the April 23, 2026 order. The order covers naturally derived delta-9-THC only when part of an FDA-approved product or state medical marijuana license. Synthetically derived cannabinoids, including delta-10-THC, remain Schedule I. Previously scheduled synthetic products like Marinol and Syndros are also unaffected by the rescheduling.
3. The 280E Tax Burden Stays for Recreational Businesses
The removal of Section 280E restrictions is the most celebrated financial change from the April 23 order — but it applies only to state-licensed medical marijuana businesses. Recreational operators remain fully subject to 280E. They cannot deduct ordinary business expenses. Their effective federal tax rates remain in the 70 to 80 percent range, according to Cannabis Regulators Association data. Since 2018, cannabis businesses collectively paid an estimated $15 billion in excess 280E-related federal taxes, per Whitney Economics. Recreational operators see none of that relief under the current order. Whether the June 29, 2026 hearing extends 280E relief to recreational businesses depends entirely on whether broader rescheduling proceeds and holds up to legal challenge.
4. Banking Access Isn't Fixed
Federal banking restrictions on cannabis businesses stem primarily from the Bank Secrecy Act's anti-money-laundering framework, not scheduling status alone. Under the BSA, financial institutions processing proceeds from federally illegal drug activity risk money laundering exposure and potential loss of FDIC insurance, regardless of scheduling. Schedule III reduces one layer of federal legal risk for medical marijuana businesses — but it does not automatically grant them access to federally insured bank accounts, payment processing, or standard financial services. The SAFE Banking Act, which would provide an explicit federal safe harbor for banks serving state-legal cannabis businesses, has not passed as of April 2026. Many cannabis businesses, including medical ones, continue to operate largely in cash.
Does marijuana rescheduling fix cannabis banking access?
Not fully, and not automatically. Banking restrictions stem primarily from the Bank Secrecy Act's anti-money-laundering framework, not just scheduling. Schedule III reduces federal legal risk for medical marijuana businesses but does not automatically grant federally insured banking access. The SAFE Banking Act — which would provide an explicit federal safe harbor for banks serving state-legal cannabis businesses — has not passed as of April 2026. Some improvement in banking access for medical operators may occur as compliance risk perception shifts, but it is not guaranteed by the scheduling change alone.
5. Prior Convictions Are Not Expunged
The April 23, 2026 rescheduling order does not expunge or modify any prior marijuana conviction. Rescheduling changes classification going forward — it does not retroactively alter the legal status of prior criminal proceedings or the collateral consequences that follow them. Impacts on federal housing assistance eligibility, federal student loan access, employment background checks, firearm ownership rights under ATF Form 4473, and immigration status remain in place for anyone with a marijuana conviction. Congressional action — not administrative rescheduling — is what expungement requires.
Does cannabis rescheduling expunge prior marijuana convictions?
No. The April 23, 2026 rescheduling order does not expunge or modify any prior marijuana convictions. Rescheduling changes classification going forward; it does not retroactively alter prior criminal proceedings. Collateral consequences — impacts on housing, employment, federal benefits, firearm rights, and immigration status — remain in place. Congressional action would be required for any retroactive relief.
6. Federal Employees, Military, Veterans, and Contractors
Federal employees subject to federal drug testing policies are not protected by the rescheduling order. The Department of Defense, federal law enforcement agencies, transportation sector employees subject to DOT drug testing, and many federal contract employees remain subject to zero-tolerance policies that Schedule III status doesn't change. VHA Directive 1315 prohibits VA doctors from recommending medical marijuana — that directive stands. For non-citizens, marijuana-related activity can still trigger inadmissibility and deportation under the Immigration and Nationality Act, regardless of state legality or federal rescheduling. The INA provisions treating controlled substance violations as grounds for inadmissibility are not modified by the scheduling order.
What Would Full Federal Marijuana Legalization Actually Require?
Full federal legalization would require an act of Congress removing cannabis from the Controlled Substances Act entirely — descheduling, not rescheduling. The MORE Act (Marijuana Opportunity Reinvestment and Expungement Act) and the Cannabis Administration and Opportunity Act have both been proposed as vehicles for exactly that. Neither has passed. Descheduling would remove federal criminal penalties for personal use, allow interstate commerce, structurally resolve the banking problem through eliminating the underlying federal illegality, eliminate 280E for all cannabis businesses, and remove federal collateral consequences. Schedule III rescheduling accomplishes none of these things fully. It is a meaningful and historically significant step within the existing scheduling framework — not a replacement of that framework.
For the full account of what the April 23 order did accomplish, including the June 22 DEA registration deadline for medical operators, see the primary Schedule III order analysis. For what the June 2026 DEA hearing could address for recreational cannabis, see the June hearing analysis. For current state-by-state cannabinoid legality, see the delta-9 state legal guide.
The Gap That Still Exists
Medical marijuana has federal legal recognition for the first time in American history. That is genuinely historic. And recreational marijuana, synthetic THC, banking, expungement, federal employment, and immigration consequences are all exactly where they were before April 23. The communities most affected by recreational marijuana prohibition are waiting on the June 29, 2026 hearing and whatever legal and legislative battles follow. The practical guidance remains what it was: understand which specific law applies to your specific situation, because federal law and state law are not the same thing, and as of today, they remain unreconciled for the majority of the cannabis market.
This content is for informational purposes only and does not constitute legal or medical advice. Cannabis laws at the federal and state level are subject to change. Consult a licensed attorney for guidance specific to your situation. HealthDataConsortium.org is an independent analytical publication and is not affiliated with any government entity or cannabis industry organization.
